MedPath

Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen) for Elderly With Dementia

Not Applicable
Completed
Conditions
Dementia
Interventions
Drug: MEOPA
Registration Number
NCT00822224
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

Acute pain is frequent in elderly especially in geriatrics acute care units where painful procedures are often occurring.

MEOPA represents an alternative to opioïd therapy to prevent procedural pain during the treatment of pressure ulcers.

In this study, cognitive impairment and dementia do not limit the use of MEOPA. The new approach in the management of acute procedural pain provides effective and safe analgesia in frail old patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • dementia (Folstein scoring between 0 and 25)
  • older than 75
  • health necessitating of painful care for example eschar care
Exclusion Criteria
  • bullous emphysema
  • pneumothorax

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1MEOPAUse of MEOPA during the painful care
Primary Outcome Measures
NameTimeMethod
feasibility of use of MEOPA as tolerance to mask, MEOPA inhalationone time, at the first care with MEOPA
Secondary Outcome Measures
NameTimeMethod
satisfaction rate of patientone time, at the first care with MEOPA

Trial Locations

Locations (1)

Gerontology department, Nice University Hospital

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath